a shadow
Home  /  Member Log In

If you do not have an account you can register HERE for free.

Maximizing the Effectiveness of Data Visualizations in Regulatory Submissions

March 12, 2019

Regulatory submissions for new drugs, biologics, or medical devices are replete with complex data that must be effectively communicated to the FDA/EMA review team. Data visualizations (eg, statistical graphs, plots, charts) are a way to communicate quantitative information with greater efficiency, clarity, and precision than with text alone. However, all…

Read More

What Today’s Business Leaders Can Learn from a “Powerless” Woman who Spoke Her Truth

February 24, 2019

In honor of Black History Month, I’d like to recognize Sojourner Truth, one of the nation’s greatest leaders in the abolitionist and women’s rights movements of the 1800s, and someone who can teach us all about the transformative power of speaking authentically. Ms. Truth was born into slavery as Isabella…

Read More

Steps for a Successful FDA Advisory Meeting

February 18, 2019

Listen to Jim DiBiasi, 3D Communications Founding Partner, and Christine Glenn, Head of Regulatory Excellence, Sanofi as they share their insights and expertise on how to prepare for an FDA advisory committee meeting.

Read More

Getting Access Right in 2019: Break Down Pharma’s Silos. Convene the Stakeholders –PART 2

February 6, 2019

A report published by Deloitte at the end of last year must have made for some sobering reading for pharma executives as they prepared to head off on their Christmas holidays. According to the consultancy, R&D returns for the world’s 12 largest pharmaceutical companies took a sharp dive — hitting…

Read More

Sign up for Updates

By submitting this form, I agree to receive email marketing communications from 3D Communications.

Thank you for subscribing.

Sign Up For Updates

By submitting this form, I agree to receive email marketing communications from 3D Communications.


* required field

Thank you for subscribing.
X